Sector Chart Alterity Therapeutics Limited Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.160 USD | -3.29% |
|
+3.35% | -29.87% |
| 05/10 | Alterity Therapeutics Limited Presents New Analyses of Ath434 Phase 2 Data in Multiple System Atrophy | CI |
| 16/09 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.38TCr | |||||
| 5.64TCr | |||||
| 5.46TCr | |||||
| 4.41TCr | |||||
| 4.21TCr |
Select your edition
All financial news and data tailored to specific country editions
